6533b7cffe1ef96bd1258276
RESEARCH PRODUCT
Metastatic pattern of breast cancer according to immunohistochemical defined subtypes in the transitional phase of adjuvant trastuzumab treatment.
Sherko KümmelAndreas Du BoisWolfgang WeikelAlexander QueckAlexander TrautFlorian HeitzF Lorenz-salehiJohannes HoltschmidtAnnette Fisseler-eckhoffOndra Du BoisGeorg ArnoldPhilipp Hartersubject
OncologyGynecologyCancer Researchmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseTransitional phaseBreast cancerOncologyTrastuzumabInternal medicineMedicineImmunohistochemistryskin and connective tissue diseasesbusinessneoplasmsAdjuvantmedicine.drugEarly breast cancerdescription
e11581 Background: Prognosis of early breast cancer (BC) differs significantly upon subtypes (ST). Treatment with adjuvant trastuzumab improves outcome of HER2 overexpressing BC, however, less in k...
year | journal | country | edition | language |
---|---|---|---|---|
2014-05-20 | Journal of Clinical Oncology |